Todd Foley is a Managing Director at MPM BioImpact and serves on a number of MPM portfolio company boards, including AstronauTx, Firefly Bio, MOAT Bio, Repare Therapeutics (NASDAQ: RPTX) and Tetherex Pharmaceuticals.
Todd also serves as Chairman of portfolio companies Aktis Oncology, ashibio and Crossbow Therapeutics. Todd earned his M.B.A. from Harvard Business School and his B.S. in Chemistry from the Massachusetts Institute of Technology.